Cite
Whole-Body Magnetic Resonance Imaging (MRI) for Staging Melanoma Patients in Direct Comparison to Computed Tomography (CT): Results from a Prospective Positron Emission Tomography (PET)/CT and PET/MRI Study
MLA
Christian Philipp Reinert, et al. “Whole-Body Magnetic Resonance Imaging (MRI) for Staging Melanoma Patients in Direct Comparison to Computed Tomography (CT): Results from a Prospective Positron Emission Tomography (PET)/CT and PET/MRI Study.” Diagnostics, vol. 13, no. 11, June 2023, p. 1963. EBSCOhost, https://doi.org/10.3390/diagnostics13111963.
APA
Christian Philipp Reinert, Cecilia Liang, Matthias Weissinger, Jonas Vogel, Andrea Forschner, Konstantin Nikolaou, Christian la Fougère, & Ferdinand Seith. (2023). Whole-Body Magnetic Resonance Imaging (MRI) for Staging Melanoma Patients in Direct Comparison to Computed Tomography (CT): Results from a Prospective Positron Emission Tomography (PET)/CT and PET/MRI Study. Diagnostics, 13(11), 1963. https://doi.org/10.3390/diagnostics13111963
Chicago
Christian Philipp Reinert, Cecilia Liang, Matthias Weissinger, Jonas Vogel, Andrea Forschner, Konstantin Nikolaou, Christian la Fougère, and Ferdinand Seith. 2023. “Whole-Body Magnetic Resonance Imaging (MRI) for Staging Melanoma Patients in Direct Comparison to Computed Tomography (CT): Results from a Prospective Positron Emission Tomography (PET)/CT and PET/MRI Study.” Diagnostics 13 (11): 1963. doi:10.3390/diagnostics13111963.